Investor Relations
Company Profile
Akesis Pharmaceuticals, Inc.™, is an emerging diabetes company with unique, patent-protected products that combine approved prescription drugs with the pure trace minerals vanadium and chromium. Akesis' patent estate, which includes 20 issued or filed patents, covers the combination of chromium and vanadium with most existing oral drugs for the treatment of diabetes.
More>>
| Ticker Symbol | Latest Stock Price |
|---|---|
| AKES.OB | 0.60 |
| For comprehensive stock information, please visit our Stock Information page. | |
More >>